Larry Robbins’s OSCR Holdings & Trades

First Buy
Q1 2025
Duration Held
3 Quarters
Largest Add
Q1 2025
+798,981 Shares
Current Position
408,221 Shares
$7.73 M Value

Larry Robbins's OSCR Position Overview

Larry Robbins (via Glenview Capital Management, LLC) currently holds 408,221 shares of Oscar Health, Inc. (OSCR) worth $7.73 M, representing 0.17% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 3 quarters.

Based on 13F filings, Larry Robbins has maintained this position in OSCR for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 408,221 shares. Largest reduction occurred in Q2 2025, reducing 798,981 shares.

Analysis based on 13F filings available since 2013 Q2

Larry Robbins's Oscar Health (OSCR) Holding Value Over Time

Track share changes against reported price movement

Quarterly Oscar Health (OSCR) Trades by Larry Robbins

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q1 2025 +798,981 New Buy 798,981 $13.11
Q2 2025 -798,981 Sold Out 0 $0.00
Q3 2025 +408,221 New Buy 408,221 $18.93

Larry Robbins's Oscar Health Investment FAQs

Larry Robbins first purchased Oscar Health, Inc. (OSCR) in Q1 2025, acquiring 798,981 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Larry Robbins has held Oscar Health, Inc. (OSCR) for 3 quarters since Q1 2025.

Larry Robbins's largest addition to Oscar Health, Inc. (OSCR) was in Q1 2025, adding 798,981 shares worth $10.47 M.

According to the latest 13F filing for Q3 2025, Larry Robbins's firm, Glenview Capital Management, LLC, owns 408,221 shares of Oscar Health, Inc. (OSCR), valued at approximately $7.73 M.

As of the Q3 2025 filing, Oscar Health, Inc. (OSCR) represents approximately 0.17% of Larry Robbins's publicly disclosed stock portfolio, making it one of their key holdings.

Larry Robbins's peak holding in Oscar Health, Inc. (OSCR) was 798,981 shares, as reported at the end of Q1 2025.